We are live on ! Find out more
HALO icon

Halozyme

110 hedge funds and large institutions have $861M invested in Halozyme in 2013 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 40 increasing their positions, 33 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

43% more capital invested

Capital invested by funds: $603M → $861M (+$258M)

21% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 33

19% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 16

11% more call options, than puts

Call options by funds: $8.89M | Put options by funds: $8M

0% more funds holding

Funds holding: 110110 (0)

Holders
110
Holders Change
Holders Change %
0%
% of All Funds
3.57%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.1%
New
19
Increased
40
Reduced
33
Closed
16
Calls
$8.89M
Puts
$8M
Net Calls
+$885K
Net Calls Change
+$2.4M
Name Holding Trade Value Shares
Change
Change in
Stake
Northwestern Mutual Wealth Management
126
Northwestern Mutual Wealth Management
Wisconsin
-$2K -300 Closed

HALO Hedge Fund Activity: Q3 2013 in Review

110 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q3 2013, worth a combined $861M — up 43% from $603M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new HALO positions and 16 closed out — a net gain of 3 holders — while 40 added to existing stakes and 33 trimmed.

The largest buyer was Sectoral Asset Management, adding an estimated $9.38M. The largest seller was Citadel Advisors, cutting an estimated $3.56M.

  • 110 institutional investors held Halozyme (HALO) as of Q3 2013, unchanged from Q2 2013.
  • Funds reported $861M of Halozyme stock for Q3 2013, up 43% quarter-over-quarter.
  • 19 funds opened new Halozyme positions in Q3 2013 and 16 closed out, a net change of +3 holders.
  • The largest Halozyme buyer in Q3 2013 was Sectoral Asset Management, an estimated $9.38M added.
  • The largest Halozyme seller in Q3 2013 was Citadel Advisors, an estimated $3.56M sold.

Based on aggregated 13F filings for Q3 2013.